Title - COMPOUNDS 4-(4-(4-(((2-(2,6-DIOXOPIPERIDIN-3-YL)-1-OXOISOINDOLIN-4-YL)OXY)METHYL)BENZYL)PIPERAZIN-1-YL)-3-FLUOROBENZONITRILE AND SAID COMPOUNDS FOR USE IN A METHOD OF TREATING MULTIPLE MYELOMA
AR112268B1Active Publication Date: 2026-08-26CELGENE CORP
View PDF 0 Cites -1 Cited by
Patent Information
- Application Number
- ARP20180101905
- Authority / Receiving Office
- AR · AR
- Patent Type
- Patents
- Current Assignee / Owner
- Priority Date
- 2018-05-23
- Filing Date
- 2018-07-06
- Publication Date
- 2026-08-26
- Estimated Expiration
- 2038-07-06
Abstract
4-(4-(4-(((2-(2,6-dioxopiperidin-3-yl)-1-oxoisoindolin-4-yl)oxy)methyl)benzyl)piperazin-1-yl)-3-fluorobenzonitrile, or an enantiomer, a mixture of enantiomers, a tautomer, or a pharmaceutically acceptable salt thereof, and methods for treating, preventing, or managing multiple myeloma using such compounds are provided. Also, pharmaceutical compositions comprising the compounds, and methods of using the compositions. Claim 1: A compound wherein the compound is Compound 1 of formula (1) or an enantiomer, mixture of enantiomers, tautomer, isotopologue, or a pharmaceutically acceptable salt thereof.
Need to check novelty before this filing date? Find Prior Art
Claims
1. A compound characterized in that the compound is Compound 1 of formula (FORMULA 1) or an enantiomer, mixture of enantiomers, or a pharmaceutically acceptable salt thereof. Thirty claims follow.